Bristol Myers Squibb to Report Results for Second Quarter 2022 on July 27, 2022 Pharmaceutical Investing
Merck to Participate in the 2022 Goldman Sachs 43rd Annual Global Healthcare Conference Life Science Investing
AbbVie to Present Extensive Data from its Migraine Portfolio at the 2022 American Headache Society® Annual Scientific Meeting Pharmaceutical Investing
Bristol Myers Squibb to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference Pharmaceutical Investing
Merck and Ridgeback Announce New Data For Investigational LAGEVRIO From Phase 3 MOVe-OUT Study Life Science Investing
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Turning Point Therapeutics, Inc. , UB Bancorp , Sprague Resources LP , Gesher I Acquisition Corp. Pharmaceutical Investing
Final Data From Phase 3 ASCENT Study Demonstrates Trodelvy Extends Overall Survival Over Chemotherapy in Second-Line Metastatic TNBC Pharmaceutical Investing
Seegnal Inc. Establishes Strategic Commercialization Team and Appoints Arx as Investor Relations Advisor
